Jan Stern Reed - 05 Jun 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jun 2024, 19:21:24 UTC
Prior SEC filing
14 May 2024
Next SEC filing
19 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Donna Shiroma

Key filing fact

Jan Stern Reed filed Form 4 for AVITA Medical, Inc. (RCEL) on 06 Jun 2024.

Key facts

  • This page summarizes Jan Stern Reed's Form 4 filing for AVITA Medical, Inc. (RCEL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Jun 2024, 19:21.

Change

  • Previous filing in this sequence was filed on 14 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RCEL transaction

Common Stock

Award

Transaction value
Shares
+9,200
Change %
+29%
Price
Shares after
40,989
Date
05 Jun 2024
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RCEL transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
$0
Shares
+3,943
Change %
Price
$0.000000
Shares after
3,943
Date
05 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,943
Exercise price
$9.51
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.

Footnote F2

Includes unvested RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .